Sarcopenia Screening Application for Sarcopenia
Mobile Phone-Based Sarcopenia Screening Application for Early Detection of Sarcopenia
1 other identifier
observational
10
1 country
1
Brief Summary
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2025
CompletedStudy Start
First participant enrolled
June 20, 2025
CompletedFirst Posted
Study publicly available on registry
June 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2025
CompletedMay 6, 2026
April 1, 2026
3 months
June 13, 2025
April 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Sarcopenia status in mobile phone applications
Using Sarcopenia Questionnaire (SARC-F), score in numerical 0-10
6 month
Study Arms (1)
Older adults (≥60 years) visiting the Geriatric Clinic
Patients aged over 60 years completed the SARC-F questionnaire in the mobile application to assess the risk of sarcopenia
Interventions
SARC-F mobile application as a digital health intervention for sarcopenia risk assessment.
Eligibility Criteria
The accessible population is patients over 60 years of age who visit Geriatric Polyclinic in Bandung
You may qualify if:
- Patients who agree to participate in this study
- Patients over 60 years old with or without caregivers
- Patients with or without caregivers with a mobile phone
- Agree to participate in the black-box testing and sign the informed consent form
- Complete the whole sequence of the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasan Sadikin General Hospital
Bandung, West Java, 40161, Indonesia
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 27, 2025
Study Start
June 20, 2025
Primary Completion
September 20, 2025
Study Completion
September 20, 2025
Last Updated
May 6, 2026
Record last verified: 2026-04